4.8 Article

CD14 and NFAT mediate lipopolysaccharide-induced skin edema formation in mice

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 122, Issue 5, Pages 1747-1757

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI60688

Keywords

-

Funding

  1. European Union [TOLERAGE: HEALTH-F4-2008-202156, ENCITE: HEALTH-F4-2008-201842]
  2. Associazione Italiana per la Ricerca sul Cancro (AIRC)
  3. Italian Ministry of Education and Research
  4. Fondazione Cariplo [2010-0678]
  5. Regione Lombardia

Ask authors/readers for more resources

Inflammation is a multistep process triggered when innate immune cells for example, DCs sense a pathogen or injured cell or tissue. Edema formation is one of the first steps in the inflammatory response; it is fundamental for the local accumulation of inflammatory mediators. Injection of LPS into the skin provides a model for studying the mechanisms of inflammation and edema formation. While it is known that innate immune recognition of LPS leads to activation of numerous transcriptional activators, including nuclear factor of activated T cells (NFAT) isoforms, the molecular pathways that lead to edema formation have not been determined. As PGE(2) regulates many proinflammatory processes, including swelling and pain, and it is induced by LPS, we hypothesized that PGE(2) mediates the local generation of edema following LPS exposure. Here, we show that tissue-resident DCs are the main source of PGE(2) and the main controllers of tissue edema formation in a mouse model of LPS-induced inflammation. LPS exposure induced expression of microsomal PGE synthase-1 (mPGES-1), a key enzyme in PGE(2) biosynthesis. mPGES-1 activation, PGE(2) production, and edema formation required CD14 (a component of the LPS receptor) and NFAT. Therefore, tissue edema formation induced by LPS is DC and CD14/NFAT dependent. Moreover, DCs can regulate free antigen arrival at the draining lymph nodes by controlling edema formation and interstitial fluid pressure in the presence of LPS. We therefore suggest that the CD14/NFAT/mPGES-1 pathway represents a possible target for antiinflammatory therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available